Shrivastava Sanjay's most recent trade in enVVeno Medical Corporation was a trade of 135,883 Stock Options done . Disclosure was reported to the exchange on Dec. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 135,883 | 135,883 | - | - | Stock Options | |
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 24 Dec 2024 | 5,400 | 9,288 (0%) | 0% | 2.9 | 15,660 | Common Stock |
| enVVeno Medical Corp | Shrivastava Sanjay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 19,752 | 19,752 | - | - | Stock Options | |
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 13,856 | 13,856 | - | - | Stock Options | |
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 8,403 | 8,403 | - | - | Stock Options | |
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 30 Jun 2022 | 1,000 | 3,888 (0%) | 0% | 3.9 | 3,850 | Common Stock |
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,211 | 7,211 | - | - | Stock Options | |
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 388 | 0 | - | - | Restricted Stock Units | |
| enVVeno Medical Corp | Sanjay Shrivastava | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 388 | 2,888 (0%) | 0% | - | Common Stock |